|
C11ORF95 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68570000000012E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13749999997026E-06 |
| Normal-vs-Stage2 |
7.624400E-02 |
| Normal-vs-Stage3 |
7.750400E-02 |
| Normal-vs-Stage4 |
2.819400E-01 |
| Stage1-vs-Stage2 |
4.756000E-01 |
| Stage1-vs-Stage3 |
3.001600E-02 |
| Stage1-vs-Stage4 |
4.994300E-02 |
| Stage2-vs-Stage3 |
4.911600E-01 |
| Stage2-vs-Stage4 |
3.797400E-01 |
| Stage3-vs-Stage4 |
7.409200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.443140E-04 |
| Normal-vs-AfricanAmerican |
1.147790E-01 |
| Normal-vs-Asian |
1.157790E-04 |
| Caucasian-vs-AfricanAmerican |
8.635400E-01 |
| Caucasian-vs-Asian |
4.326500E-02 |
| AfricanAmerican-vs-Asian |
2.848400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.461000E-03 |
| Normal-vs-Female |
2.33109999999703E-05 |
| Male-vs-Female |
2.815600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.816799999945E-06 |
| Normal-vs-Age(41-60Yrs) |
1.649290E-04 |
| Normal-vs-Age(61-80Yrs) |
7.537200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.572000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.846200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.378200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.021800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.521400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.707800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.237800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.43460000001649E-06 |
| Classical-VS-Follicular |
4.19210000046633E-07 |
| Classical-VS-Other |
7.932200E-01 |
| Classical-VS-Normal |
7.95440002754333E-09 |
| Tall-VS-Follicular |
7.610800E-01 |
| Tall-VS-Other |
1.602840E-01 |
| Tall-VS-Normal |
4.686200E-01 |
| Follicular-VS-Other |
5.954100E-02 |
| Follicular-VS-Normal |
7.090400E-01 |
| Other-VS-Normal |
2.059600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.862800E-03 |
| Normal-vs-N1 |
9.339000E-03 |
| N0-vs-N1 |
5.910600E-01 |
|
|
